¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ : 2023-07-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ : 2023-07-07
±³À°ÀÏÀÚ : 2023-07-07
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ

±³À°ÁÖÁ¦ : 2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ
´ã´çÀÚ : Á¤È¿°æ
¿¬¶ôó : 02-2279-9560  

À̸ÞÀÏ : kscvs@hanmail.net

±³À°Á¾·ù : ½Å°æ¿Ü°ú

Âü¼®¿¹»óÀÎ : 30¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 14:00~15:00 Specific Issues in Moyamoya Disease - Optimization of recipient artery in revasculizationsurgery for moyamoya disease ¿¬Á¦¿µ(¼º±Õ°ü´ë »ï¼º¼­¿ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 15:00~16:00 Specific Issues in Moyamoya Disease - Pregnancy and heredity in patients with moyamoya disease À̽ÿî(ºÐ´ç¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

ÈÞ½Ä 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 16:00~16:30 ÈÞ½Ä ()

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 16:30~16:45 Case Presentation - 1. A Case Report : Development of a new ant.choroidal aneurysm following EDAS in a hemorrhagic Moyamoya patient ÀºÁø(°¡Å縯´ë ÀºÆò¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 16:45~17:00 Case Presentation - 2. Ruptured aneurysm in moyamoya disease ¿ÀÀç»ó(°¡Å縯´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:00~17:15 Case Presentation - 3. Two cases of complications during bypass surgery for MMS À̼ºÈ£(¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:15~17:30 Case Presentation - 4. Hyperperfusion Syndrome after Triple-Barreled STA-RAG-A1 and STA-MCA Bypass in Moyamoya Angiopathy À嵿±Ô(°¡Å縯´ë ÀÎõ¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:30~17:45 Case Presentation - 5. Transient neurological deterioration due to watershed shift after STA-MCA bypass surgery in Moyamoya disease ÁöűÙ(¼º±Õ°ü´ë »ï¼º¼­¿ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:45~18:00 Case Presentation - 6. Post OP Delayed ICH due to hyperperfusion after combined bypass surgery to MMD patient ÀÌ»óÈ¿(ºÐ´ç¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:00~18:15 Case Presentation - 7. Mortality case due to postoperative cerebral infarction following bypass surgery in a moyamoya patient ÃÖÁØÈ£(¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:15~18:30 Case Presentation - 8. Hydration-induced rapid growth and regression after indirect revascularization of an anterior choroidal artery aneurysm associated with Moyamoya disease: A case report ±èÀåÈÆ(°í·Á´ë ¾È¾Ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:30~18:45 Case Presentation - 9. Prediction of contralateral progression in nonhemorrhagic moyamoya disease after unilateral surgery ¹æâȯ(Áß¾Ó´ë ±¤¸íº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:45~19:00 Case Presentation - 10. Cerebral autoregulatory dysfunction as a main pathophysiology of postoperative cerebral hyperperfusion syndrome in adult moyamoya disease Á¶¿ø»ó(¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ : 2023-07-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦20ȸ ½É±Ù°æ»ö¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö(1ÀÏÂ÷) : 2023-07-07
´ÙÀ½±Û ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Current status and Challenages of Coronary artery disease and Aortic valvular heart disease : 2023-07-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
495 °­¿ø ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø NAFLD(non-alcoholic fatty liver disease) and Cardiometabolic Syndrome [7th Gangwon Heart Seminar 2018] : 2018-09-07 0 919 2018-08-22
494 ÀüºÏ ÀüÁÖ ¿¹¼öº´¿ø ´ëÇÑÀçÈ°ÀÇÇÐȸ È£³²Á¦ÁÖÁöȸ ÀçÈ° ½ÉÆ÷Áö¾ö : 2018-09-07 0 1,006 2018-08-22
493 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 793 2018-08-22
492 ¼­¿ï 2018³â °³¿øÀǸ¦ À§ÇÑ °­µ¿°æÈñ´ëÇб³º´¿ø ¼ÒÈ­±âÁúȯ ¿¬¼ö°­Á : 2018-09-06 0 617 2018-08-22
491 Ãæ³² ´Ü±¹´ëÇб³º´¿ø 2018³â Á¦3Â÷ ´ëÇѺ´¸®ÇÐȸ ´ëÀü¤ýÃæûÁöȸ: ÃÖ½ÅÀÇÇÐÁ¤º¸ Ư°­ ¹× º´¸®ÇÐ Áõ·Ê ¹ßÇ¥ : 2018-09-06 0 715 2018-08-22
490 ´ë±¸ ´ëÇѽŻý¾ÆÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 984 2018-08-22
489 Àü³² Á¦257Â÷ ´ëÇѳ»°úÇÐȸ ±¤ÁÖÀü³²Áöȸ Çмú´ëȸ : 2018-09-06 0 573 2018-08-22
488 °æ³² ´ëÇÑÇǺΰúÇÐȸ º£Ã¼Æ®º´ÀÇ ÃÖ½ÅÁö°ß¿¡ °üÇÏ¿© : 2018-09-06 0 678 2018-08-22
487 Ãæ³² °Ç¾ç´ëÇб³º´¿ø ´ëÇÑÇǺΰúÇÐȸ ÃæûÁöºÎÇÐȸ : 2018-09-06 0 865 2018-08-22
486 ´ë±¸ °è¸í´ëÇб³ µ¿»êÀÇ·á¿ø ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦234Â÷ °æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 730 2018-08-22
485 °æ±â °¡Å縯´ëÇб³ ºÎõ¼º¸ðº´¿ø ´ëÇѺñ´¢±â°úÇÐȸ 2018 Á¦ 3Â÷ ÀÎõ.°æ±âÁöȸ Áý´ãȸ : 2018-09-06 2 1,451 2018-08-22
484 °æ³² ´ëÇÑÈäºÎ¿Ü°úÇÐȸ 2018³âµµ 3Â÷ ºÎ»ê¿ï»ê°æ³² ÈäºÎ¿Ü°ú Áý´ãȸ ¹× °­¿¬ : 2018-09-06 0 686 2018-08-22
483 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 0 528 2018-08-22
482 ºÎ»ê ºÎ»ê±¤¿ª½ÃÀÇ»çȸ ¼­±¸ÀÇ»çȸ 9¿ù Çмúȸ : 2018-09-05 0 623 2018-08-22
481 ´ë±¸ 2018³â ´ëÇÑ°¨¿°ÇÐȸ ¿µ³²Áöȸ 9¿ù Áý´ãȸ : 2018-09-05 0 467 2018-08-22
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷